ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07725
-0,01%
Bitcoin
63.574,22
1,08%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. ImmunoGen Inc (IMGN)

  7. ImmunoGen Inc (IMGN) News

IMGN ImmunoGen Inc

31,235
0,00 (0,00%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
ImmunoGen Inc IMGN NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,00 0,00% 31,235 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
31,235 31,235
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
22.2.202422:15EDGAR2Form 15-12G - Securities registration termination [Section..
14.2.202423:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202422:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12.2.202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202422:33EDGAR2Form S-8 POS - Securities to be offered to employees in..
12.2.202415:32EDGAR2Form 25-NSE - Notification filed by national security..
12.2.202413:52EDGAR2Form 8-K - Current report
12.2.202413:37PRNUSAbbVie Completes Acquisition of ImmunoGen
08.2.202413:08EDGAR2Form 8-K - Current report
07.2.202413:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07.2.202403:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202403:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202403:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202403:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202403:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202403:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202403:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202403:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202403:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202403:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202403:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202403:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.2.202422:10EDGAR2Form 144 - Report of proposed sale of securities
05.2.202422:09EDGAR2Form 144 - Report of proposed sale of securities
05.2.202422:08EDGAR2Form 144 - Report of proposed sale of securities
05.2.202422:07EDGAR2Form 144 - Report of proposed sale of securities
01.2.202422:30BWImmunoGen Announces Inducement Grants Under Nasdaq Listing..
31.1.202422:12EDGAR2Form 8-K - Current report
29.1.202423:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29.1.202423:00EDGAR2Form 8-K - Current report
24.1.202422:57EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
24.1.202422:55EDGAR2Form 8-K - Current report
19.1.202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.1.202422:20EDGAR2Form 144 - Report of proposed sale of securities
12.1.202417:10PRNUSKuehn Law Encourages PXD, IMGN, HA and ICVX Investors to..

Kürzlich von Ihnen besucht

NASDAQ
IMGN
ImmunoGen
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten